BGXX (BGXX)
Bright Green Corporation
OTC:BGXXHealthcare · Drug Manufacturers - Specialty & Generic
Mkt Cap-
Float71.6M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$401K
Net Income-$13.13M
Total Assets$17.4M
Free Cash Flow-$4.99M
Debt & Equity
Debt 14%
Equity 86%
Total Debt$1.85M
Total Equity$10.96M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in BGXX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$17.4M
Liabilities$6.44M
Accounts Receivable$0
Accounts Payable$4.18M
Inventory$0
PP&E (Net)$16.41M
Goodwill$0
Intangible Assets$1K
Income Statement
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $401K | $204K | $0 | $0 | $0 |
| YoY Growth | 97.2% | - | - | - | - |
| Cost of Revenue | $639K | $705K | $752K | $838K | $528K |
| Gross Profit | -$237K | -$501K | -$752K | -$838K | -$528K |
| Gross Margin | -59.0% | -246.2% | - | - | - |
| Research and Development | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $8.2M | $26.32M | $1.74M | $2.11M | $342K |
| Other | $57K | $291K | $752K | $0 | $0 |
| Total Operating Expenses | $8.25M | $26.61M | $2.49M | $2.11M | $342K |
| Operating Income (EBIT) | -$8.89M | -$27.31M | -$2.49M | -$2.95M | -$870K |
| Operating Margin | -2214.6% | -13418.5% | - | - | - |
| Interest Expense | $0 | $213K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$4.02M | -$213K | $0 | -$104K | $4 |
| Income Before Tax (EBT) | -$12.91M | -$27.53M | -$2.49M | -$3.05M | -$870K |
| Income Tax Expense | $219K | $561K | $0 | $104K | $0 |
| Net Income | -$13.13M | -$27.66M | -$2.49M | -$3.05M | -$870K |
| Net Income Margin | -3269.7% | -13589.6% | - | - | - |
| Supplementary Data | |||||
| EPS | -0.07 | -0.17 | -0.02 | -0.02 | -0.01 |
| Diluted EPS | -0.07 | -0.17 | -0.02 | -0.02 | -0.01 |
| Weighted Average OS | 178.57M | 162.06M | 158.36M | 158.36M | 158.36M |
| EBITDA | -$8.25M | -$26.61M | -$1.74M | -$2.01M | -$342K |
| EBITDA Margin | -2055.6% | -13072.3% | - | - | - |
Balance Sheet
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||
| Current Assets | |||||
| Cash and Cash Equivalents | $10K | $415K | $1.28M | $102K | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $10K | $415K | $1.28M | $102K | $0 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $258K | $78K | $0 | $0 | $58K |
| Total Current Assets | $268K | $492K | $1.45M | $121K | $58K |
| Long-Term Assets | |||||
| Property, Plant & Equipment Net | $16.41M | $17.15M | $7.33M | $7.78M | $8.6M |
| Goodwill | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1K | $1K | $1K | $1K | $0 |
| Long-Term Investments | $726K | $3.99M | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $1.16M | $0 | $0 | $0 |
| Total Long-Term Assets | $17.13M | $22.3M | $7.33M | $7.78M | $8.6M |
| Other Assets | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $17.4M | $22.79M | $8.78M | $7.9M | $8.66M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | $4.18M | $5.03M | $150K | $180K | $83K |
| Short-Term Debt | $1.65M | $2.04M | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $90K |
| Total Current Liabilities | $6.24M | $7.52M | $168K | $297K | $172K |
| Long-Term Liabilities | |||||
| Long-Term Debt | $202K | $3.69M | $392K | $383K | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $202K | $3.69M | $392K | $383K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $6.44M | $11.21M | $560K | $679K | $172K |
| Stockholders' Equity | |||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $18K | $17K | $16K | $16K | $12K |
| Retained Earnings | -$47.2M | -$34.08M | -$6.41M | -$3.92M | -$870K |
| Comprehensive Income & Other | $0 | $0 | $0 | $138 | $0 |
| Other Stockholders' Equity | $58.15M | $45.64M | $14.62M | $11.13M | $9.34M |
| Total Equity | $10.96M | $11.58M | $8.22M | $7.22M | $8.49M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $17.4M | $22.79M | $8.78M | $7.9M | $8.66M |
| Supplementary Data | |||||
| Total Debt | $1.85M | $5.73M | $392K | $383K | $0 |
| Net Debt | $1.84M | $5.31M | -$890K | $280K | $0 |
Cash Flow Statement
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||
| Net Income | -$13.13M | -$27.66M | -$2.49M | -$3.05M | -$870K |
| Depreciation & Amortization | $639K | $705K | $752K | $838K | $528K |
| Deferred Income Tax | $0 | $0 | -$1.89M | $0 | -$974K |
| Stock-Based Compensation | $3.83M | $18.83M | $360K | $1.43M | $42K |
| Changes in Working Capital: | |||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.82M | $4.88M | -$30K | $98K | $83K |
| Other Working Capital | $146K | $626K | -$247K | $66K | $31K |
| Total Working Capital Change | $1.97M | $5.51M | -$278K | $164K | $114K |
| Other Non-Cash Items | $4.23M | $348K | $1.89M | $104K | $959K |
| Net Cash from Operating | -$2.46M | -$2.27M | -$1.66M | -$513K | -$200K |
| Investing Activities | |||||
| Capital Expenditures | -$2.53M | -$11.68M | -$303K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$2.69M | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$2.53M | -$14.37M | -$303K | $0 | $0 |
| Financing Activities | |||||
| Debt Repaid | -$400K | -$3.58M | - | - | - |
| Common Stock Issuance | $3.98M | $12.19M | $3.13M | $233K | $200K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $200K | $0 | $10K | $383K | $200K |
| Net Cash from Financing | $4.58M | $15.77M | $3.14M | $616K | $200K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$405K | -$868K | $1.18M | $102K | $0 |
| Supplementary Data | |||||
| Operating Cash Flow | -$2.46M | -$2.27M | -$1.66M | -$513K | -$200K |
| Capital Expenditure | -$2.53M | -$11.68M | -$303K | $0 | $0 |
| Free Cash Flow | -$4.99M | -$13.95M | -$1.96M | -$513K | -$200K |
| Cash at Beginning | $415K | $1.28M | $102K | $0 | $0 |
| Cash at End | $10K | $415K | $1.28M | $102K | $0 |